| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22:26 | AURORA CANNABIS INC - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 22:18 | Artivion Non-GAAP EPS of $0.17 misses by $0.01, revenue of $116M misses by $0.41M | 1 | Seeking Alpha | ||
| 22:17 | Aurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical Cannabis | 4 | CNW | ||
| 22:16 | ALNYLAM PHARMACEUTICALS, INC. - S-8, Securities to be offered to employees in employee benefit plans | 3 | SEC Filings | ||
| 22:10 | Amid Wegovy pill's flying start in US, Novo CEO eyes Ireland expansion for supply overseas: Bloomberg | 6 | FiercePharma | ||
| 22:10 | ARTIVION, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 22:10 | Aclaris auf Guggenheim-Gipfel: Strategische Entwicklungen in der Biotech-Pipeline | 1 | Investing.com Deutsch | ||
| 22:06 | Pacira BioSciences: Pacira to Report 2025 Financial Results on Thursday February 26, 2026 | 4 | GlobeNewswire (USA) | ||
| 22:06 | Prothena Corporation plc: Prothena to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 | 121 | Business Wire | Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced... ► Artikel lesen | |
| 22:06 | BridgeBio Pharma, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22:05 | Eli Lilly builds $1.5 billion stockpile of weight-loss pill ahead of FDA decision | 2 | Reuters | ||
| 22:05 | SOLIGENIX, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 22:04 | VERTEX PHARMACEUTICALS INC / MA - 8-K, Current Report | 14 | SEC Filings | ||
| 21:55 | Nach Merck-Ausstieg: Belén Garijo rückt an Sanofis Spitze | 4 | FAZ | ||
| 21:21 | VASO Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 21:12 | Camurus AB (publ) GAAP EPS of SEK1.67, revenue of SEK464M | 2 | Seeking Alpha | ||
| 20:46 | BridgeBio Stands Tall as Phase 3 Data Put Dwarfism Drug on Track for FDA Filing | 2 | MedCity News | ||
| 20:42 | Sanofi Appoints Belén Garijo as CEO | 6 | Contract Pharma | ||
| 20:42 | AbbVie files lawsuit over selection of Botox for Medicare price negotiations | 4 | Seeking Alpha | ||
| 20:30 | Stimmungswechsel bei Novo nordisk: Diese Entwicklung macht misstrauisch - sofort handeln! | Hebelschein-Spekulant |
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| SANOFI | 30 | 42 | -3,26 % | Sanofi holt Merck-Chefin Garijo als CEO | DJ Sanofi holt Merck-Chefin Garijo als CEO
Von Billy Gray
DOW JONES--Sanofi wechselt den CEO aus. Wie der französische Pharmakonzern mitteilte, hat er das Mandat von Paul Hudson nicht verlängert.... ► Artikel lesen | ||
| NOVO NORDISK | 19 | 40 | +0,11 % | Die Umsätze von Novo Nordisk sollen stärker als bisher gedacht nachgeben und die Aktie reagiert darauf mit einem veritablen Kurssturz | Die Novo Nordisk-Aktie startete mit viel Schwung und positiven Schlagzeilen ins neue Jahr. Bereits im Dezember konnten die Dänen in den USA eine Zulassung für eine Tablettenform des Abnehmmittels Wegovy... ► Artikel lesen | ||
| ZOETIS | 10 | 1 | -2,23 % | Zoetis Inc. Announces Climb In Q4 Bottom Line | WASHINGTON (dpa-AFX) - Zoetis Inc. (ZTS) reported a profit for its fourth quarter that Increases, from the same period last yearThe company's earnings totaled $603 million, or $1.37 per share.... ► Artikel lesen | ||
| BRIDGEBIO PHARMA | 10 | - | +4,11 % | BridgeBio Pharma, Inc.: BridgeBio Reports Positive Phase 3 Topline Results for Oral Infigratinib with the First Statistically Significant Improvements in Body Proportionality in Achondroplasia | - PROPEL 3 successfully met the primary endpoint of change from baseline in AHV at Week 52 (p - Change from baseline in AHV was superior to placebo at Week 52 with a mean treatment difference against... ► Artikel lesen | ||
| MERCK KGAA | 9 | 15 | +0,04 % | JPMORGAN stuft MERCK KGAA auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Merck KGaA mit einem Kursziel von 150 Euro auf "Overweight" belassen. Analyst Richard Vosser geht davon aus, dass der Ausblick... ► Artikel lesen | ||
| ALNYLAM PHARMACEUTICALS | 8 | 9 | -4,50 % | Alnylam Pharmaceuticals Reports Net Income In Q4 | WASHINGTON (dpa-AFX) - Alnylam Pharmaceuticals, Inc. (ALNY) reported fourth quarter net income of $111.5 million compared to a loss of $83.8 million, prior year. GAAP net income per common share... ► Artikel lesen | ||
| BAYER | 7 | 36 | -0,94 % | Märkte am Morgen: Bitcoin rauscht ab - Gold, Silber, Strategy, Amazon, UnitedHealth, SAP, Bayer | Der DAX kommt weiter nicht in die Gänge. Gestern startete der Leitindex zwar ordentlich, rutschte dann aber deutlich ab. Immerhin reduzierte er seine Verluste kurz vor Handelsende etwas. Heute deuten... ► Artikel lesen | ||
| IPSEN | 7 | - | +6,16 % | Ipsen Full-Year Profit Rises On Higher Sales; Sees Over 13% Sales Growth In 2026 | PARIS (dpa-AFX) - Ipsen S.A. (IPSEY), a specialty-care biopharmaceutical company, on Thursday reported higher earnings for 2025, supported by stronger sales performance.Net income attributable... ► Artikel lesen | ||
| AVADEL PHARMACEUTICALS | 6 | 6 | 0,00 % | XFRA AWK: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILAVADEL PHARMACEUTICALS... ► Artikel lesen | ||
| WEST PHARMACEUTICAL SERVICES | 6 | 3 | +1,25 % | West Pharmaceutical Q4 Earnings Rise; Guides FY26 | WASHINGTON (dpa-AFX) - West Pharmaceutical Services, Inc. (WST), on Thursday, reported its higher net income in the fourth quarter compared with the previous year and issued an outlook for the... ► Artikel lesen |
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| DOCMORRIS AG | 6,215 | 8,88 | +43 % | 4 | 5 | 3 | |||
| SCHOTT PHARMA AG & CO KGAA | 14,960 | 19,20 | +28 % | 9 | 14 | - | |||
| SANOFI SA | 79,82 | 97,62 | +22 % | 17 | 17 | - | |||
| NOVO NORDISK A/S | 41,095 | 48,06 | +17 % | 25 | 18 | 5 | |||
| MERCK KGAA | 125,40 | 139,40 | +11 % | 9 | 4 | - | |||
| ELI LILLY AND COMPANY | 875,90 | 968,78 | +11 % | 1 | - | - | |||
| PFIZER INC | 23,195 | 23,83 | +3 % | 1 | 7 | - | |||
| ROCHE HOLDING AG GS | 394,05 | 378,42 | -4 % | 13 | 21 | 5 | |||
| NOVARTIS AG | 135,34 | 124,89 | -8 % | 10 | 10 | 3 | |||
| DERMAPHARM HOLDING SE | 36,900 | 34 | -8 % | - | 1 | - | |||
| ASTRAZENECA PLC | 172,30 | 158,27 | -8 % | 17 | 1 | 5 | |||
| BAYER AG | 45,690 | 39,69 | -13 % | 20 | 14 | - | |||
| GSK PLC | 24,620 | 20,62 | -16 % | 3 | 12 | 9 |